FindTrial
Sign In

eye diseases in children of nephrotic syndrome on steroids

Ocular complications in children of nephrotic syndrome on oral steroids - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057206
Enrollment
90
Registered
2023-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H263- Drug-induced cataract Health Condition 2: N049- Nephrotic syndrome with unspecified morphologic changes Health Condition 3: H409- Unspecified glaucoma

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: nephrotic syndrome children aged 5 to 18 years on oral corticosteroids for at least 12 weeks

Exclusion criteria

Exclusion criteria: Children using topical steroids Children with developmental cataract and congenital glaucoma Prior ocular trauma Children with optic disc anomaly

Design outcomes

Primary

MeasureTime frame
Proportion of glaucoma & cataract in children using oral steroidsTimepoint: baseline with no follow up—

Secondary

MeasureTime frame
Level of awareness among caregivers of children & physicians regarding ocular side effects of steroid useTimepoint: baseline—

Countries

India

Contacts

Public ContactDr Sanat Kumar

Maulana Azad Medical College

gnecdir@gmail.com9968604334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026